Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Collaboration    crawled date : 2021 - 05 - 04    save search

908 Devices and Bio-Techne Announce Joint Collaboration
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
MASS | $5.59 0.18% 0.0% 130K twitter stocktwits trandingview |
| | O: -0.25% H: 0.19% C: -0.57%
TECH | $62.8 1.1% 1.07% 830K twitter stocktwits trandingview |
Health Technology
| | O: -1.19% H: 0.67% C: -0.74%

collaboration device
Bio-Techne and 908 Devices Announce Joint Collaboration
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
MASS | $5.59 0.18% 0.0% 130K twitter stocktwits trandingview |
| | O: -0.25% H: 0.19% C: -0.57%
TECH | $62.8 1.1% 1.07% 830K twitter stocktwits trandingview |
Health Technology
| | O: -1.19% H: 0.67% C: -0.74%

collaboration device
Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements– Agreements are a major step for ongoing clinical trials and future commercial drug supply
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
PSTV | News | $1.66 1.84% -3.16% 200K twitter stocktwits trandingview |
Health Technology
| | O: 15.77% H: 17.61% C: -20.27%

ongoing clinical trials collaboration drug trial chmp
Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements
Published: 2021-05-04 (Crawled : 12:00) - globenewswire.com
PSTV | News | $1.66 1.84% -3.16% 200K twitter stocktwits trandingview |
Health Technology
| | O: 15.77% H: 17.61% C: -20.27%

collaboration drug chmp
Evotec and the GCKD Study Enter into Strategic Collaboration to Build A Unique Molecular Patient Database
Published: 2021-05-04 (Crawled : 08:00) - biospace.com/
SNY | News | $47.15 1.84% 1.75% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.32% C: -0.59%

unique collaboration molecular
Press news Biocartis Group NV: Biocartis Announces New Collaboration with AstraZeneca to Expand Availability of Idylla™ EGFR Biomarker Testing Among Patients with Lung Cancer
Published: 2021-05-04 (Crawled : 06:00) - globenewswire.com
AZN | News | $70.13 2.31% 2.24% 4.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.8% H: 0.21% C: -0.64%

lung cancer test collaboration cancer biomarkers
Gainers vs Losers
73% 27%

Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M twitter stocktwits trandingview |

AGBA | $2.5 100.0% 56.6% 200M twitter stocktwits trandingview |
Finance

MLEC | $2.47 76.43% 42.62% 78M twitter stocktwits trandingview |
n/a

NUWE | $0.334 29.96% 40.99% 2.5M twitter stocktwits trandingview |
Manufacturing

EDBL | News | $6.26 66.49% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.86 46.25% 32.8% 180K twitter stocktwits trandingview |

VIVK | $1.43 33.65% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.7M twitter stocktwits trandingview |

SDIG A | $3.64 35.32% 26.0% 990K twitter stocktwits trandingview |

PROK | $2.72 33.33% 24.58% 2.6M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.